112 results on '"MIRTAZAPINE"'
Search Results
2. Selective Noradrenergic Activation of BDNF Translation by Mirtazapine
3. Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study
4. Mirtazapine loaded polymeric micelles for rapid release tablet: A novel formulation—In vitro and in vivo studies
5. A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial
6. Compatibility study of mirtazapine with several excipients used in pharmaceutical dosage forms employing thermal and non-thermal methods
7. Pharmacological update of mirtazapine: a narrative literature review
8. Edema related to treatment with psychotropic drugs
9. Prazosin Enhances the Effectiveness of Mirtazapine on Anxiety- and Depression-Like Behaviors in Rats during Cocaine Withdrawal
10. Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study
11. Design of mirtazapine solid dispersion with different carriers’ systems: optimization, in vitro evaluation, and bioavailability assessment
12. A case of progressive multifocal leukoencephalopathy in a post-kidney transplant patient with improvement after discontinuation of immunosuppressive drugs and combination therapy with mefloquine and mirtazapine
13. Mirtazapine-induced neutropenic sepsis in an older person: a case report
14. The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis
15. Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men
16. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report
17. Trait sensitivity to negative feedback determines the effects of chronic stress and chronic mirtazapine treatment on anxiety and stress-coping strategies in rats
18. Effect of Mirtazapine on Craving in Cocaine-Dependent Patients
19. Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort
20. Propensity score-matching analysis comparing safety outcomes of appetite-stimulating medications in oncology patients
21. Pharmacologic Approaches to Insomnia and Other Sleep Disorders in Children
22. Progressive multifocal leukoencephalopathy in a patient with mediastinal teratoma: a case report
23. The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records
24. JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient
25. Long-Term Survival after Progressive Multifocal Leukoencephalopathy in a Patient with Primary Immune Deficiency and NFKB1 Mutation
26. Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study
27. Efficacy of Antidepressants in the Treatment of Obstructive Sleep Apnea Compared to Placebo. A Systematic Review with Meta-Analyses.
28. Neuroprotective effects of mirtazapine and imipramine and their effect in pro- and anti-apoptotic gene expression in human neuroblastoma cells
29. What is the evidence for mirtazapine in treating cancer-related symptomatology? A systematic review
30. Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial
31. Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review
32. A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
33. Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis
34. Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction”
35. Medication and medical diagnosis as risk factors for falls in older hospitalized patients
36. Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report
37. The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex
38. Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report
39. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
40. Cardiac arrest induced by the intentional ingestion of boric acid and mirtazapine treated by percutaneous cardiopulmonary bypass: a case report
41. Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats
42. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study
43. Chronic Pruritus: Current and Emerging Treatment Options
44. Treatment options for hyperemesis gravidarum
45. The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset
46. Pisa syndrome associated with mirtazapine: a case report
47. Development of a novel ultrasonic-assisted magnetic dispersive solid-phase microextraction method coupled with high performance liquid chromatography for determination of mirtazapine and its metabolites in human urine and water samples employing experimental design
48. The theoretical investigation of solvent effects on the relative stability and 15N NMR shielding of antidepressant heterocyclic drug
49. Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine
50. Distribution pattern of mirtazapine and normirtazapine in blood and CSF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.